Abstract | UNLABELLED: Choice of the donor site for a split thickness skin graft depends on skin availability, possible complications and anticipated esthetic results. We selected the scalp to be the primary donor site at our institution. During a period of ten years (1998-2008), a group of 123 pediatric patients aged 4 months to 15 years (65% were below the age of 2; mean age 2.98 years) underwent skin grafting from this particular site. In 2 cases the same area was re-harvested. All donor sites healed by the 10th post-operative day. Donor site complications included: 2 microalopecia regions, 5 pressure sores in a close proximity, 1 hypertrophic scar and 1 visible mark on the forehead due to technical mistake in graft harvesting. All children started scar management of the recipient site with contact therapy using adhesive tape Hypafix (BSN Medical); subsequently moving on to silicone sheets or gel in selected refractory cases. We present results for 68 scars in 41 patients with the longest follow-up period. Scar quality was evaluated after minimum of 10 years and scored according to the Vancouver Scar Assessment Scale. Very good and good results were obtained in 55 scars (80.9%), satisfactory in 11 scars (16.2%) and unsatisfactory in 2 scars (2.9%). CONCLUSIONS: Our results confirm, that the scalp is a reliable donor site in children and contact therapy is an adequate form of scar prevention/treatment of the recipient site.
|
Authors | D Wyrzykowski, B Chrzanowska, P Czauderna |
Journal | Burns : journal of the International Society for Burn Injuries
(Burns)
Vol. 41
Issue 2
Pg. 359-63
(Mar 2015)
ISSN: 1879-1409 [Electronic] Netherlands |
PMID | 25234957
(Publication Type: Journal Article)
|
Copyright | Copyright © 2014 Elsevier Ltd and ISBI. All rights reserved. |
Chemical References |
- Emollients
- Gels
- Silicones
|
Topics |
- Adolescent
- Burns
(complications, surgery)
- Child
- Child, Preschool
- Cicatrix, Hypertrophic
(etiology, prevention & control, therapy)
- Emollients
(therapeutic use)
- Female
- Gels
(therapeutic use)
- Humans
- Infant
- Male
- Scalp
(transplantation)
- Silicones
(therapeutic use)
- Skin Transplantation
(methods)
- Time Factors
- Transplant Donor Site
|